These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24771047)

  • 1. Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.
    Aleskandarany MA; Negm OH; Green AR; Ahmed MA; Nolan CC; Tighe PJ; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2014 Jun; 145(2):339-48. PubMed ID: 24771047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
    Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
    Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression.
    Jørgensen CLT; Forsare C; Bendahl PO; Falck AK; Fernö M; Lövgren K; Aaltonen K; Rydén L
    Breast Cancer Res Treat; 2020 Jun; 181(2):369-381. PubMed ID: 32300922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype.
    Jeong H; Ryu YJ; An J; Lee Y; Kim A
    Histopathology; 2012 May; 60(6B):E87-95. PubMed ID: 22439911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis.
    Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Paish EC; Macmillan RD; Ellis IO; Green AR
    Breast Cancer Res Treat; 2010 Jul; 122(1):45-53. PubMed ID: 19701705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
    McCart Reed AE; Kutasovic JR; Vargas AC; Jayanthan J; Al-Murrani A; Reid LE; Chambers R; Da Silva L; Melville L; Evans E; Porter A; Papadimos D; Thompson EW; Lakhani SR; Simpson PT
    J Pathol; 2016 Mar; 238(4):489-94. PubMed ID: 26510554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.
    Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Ellis IO; Green AR
    Breast Cancer Res Treat; 2011 Jun; 127(2):407-16. PubMed ID: 20617378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
    Costa LC; Leite CF; Cardoso SV; Loyola AM; Faria PR; Souza PE; Horta MC
    J Appl Oral Sci; 2015; 23(2):169-78. PubMed ID: 26018309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of reverse phase protein array for molecular classification of breast cancer.
    Negm OH; Muftah AA; Aleskandarany MA; Hamed MR; Ahmad DA; Nolan CC; Diez-Rodriguez M; Tighe PJ; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2016 Jan; 155(1):25-35. PubMed ID: 26661092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
    Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale.
    Paliwal P; Arora D; Mishra AK
    Indian J Pathol Microbiol; 2012; 55(4):443-9. PubMed ID: 23455777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
    Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
    J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis.
    Liu JB; Feng CY; Deng M; Ge DF; Liu DC; Mi JQ; Feng XS
    World J Surg Oncol; 2017 Aug; 15(1):139. PubMed ID: 28764784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of e-cadherin in primary breast cancer and corresponding lymph node metastases.
    Fulga V; Rudico L; Balica AR; Cimpean AM; Saptefrati L; Margan MM; Raica M
    Anticancer Res; 2015 Feb; 35(2):759-65. PubMed ID: 25667455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.
    Mohammadizadeh F; Ghasemibasir H; Rajabi P; Naimi A; Eftekhari A; Mesbah A
    Cancer Biomark; 2009; 5(1):1-8. PubMed ID: 19242056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.
    Pomp V; Leo C; Mauracher A; Korol D; Guo W; Varga Z
    Breast Cancer Res Treat; 2015 Nov; 154(1):45-55. PubMed ID: 26467042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways.
    Jerjees DA; Negm OH; Alabdullah ML; Mirza S; Alkaabi M; Hameed MR; Abduljabbar R; Muftah A; Nolan CC; Green AR; Tighe PJ; Band V; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2015 Feb; 150(1):91-103. PubMed ID: 25701120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.
    Abd El-Rehim DM; Ball G; Pinder SE; Rakha E; Paish C; Robertson JF; Macmillan D; Blamey RW; Ellis IO
    Int J Cancer; 2005 Sep; 116(3):340-50. PubMed ID: 15818618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.